Ligand Pharmaceuticals Inc (LGND)

Investing Cash Flow

$321.12M

Quarterly · Period ending: · USD

LGND logo

LGND Investing Cash Flow

Latest reported$321.12M
LGND Quarterly Cash from Investing ($3.50M → $321.12M)
High-resolution chart · PNG

LGND investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
1,969,000
-5,629,000
5,735,000
4,242,000
471,000
4,203,000
-900,000
-30,800,000
6,300,000
500,000
-22,600,000
2,700,000
7,600,000
-16,300,000
3,000,000
5,200,000
3,100,000
-7,000,000
-7,000,000
6,600,000
3,200,000
4,700,000
5,100,000
3,900,000
18,300,000
-5,600,000
3,200,000
3,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.